Theratechnologies Receives Update from FDA on Tesamorelin F8 Supplemental Biologic License Application.

Linked as:


Document options

Extract

Theratechnologies Receives Update from FDA on Tesamorelin F8 Supplemental Biologic License Application.

No longer available (Autolink)

See the full content of this document